Calcineurin inhibitor-based immunosuppressive therapy, donor age, and long-term outcome after kidney transplantation

Transplantation

Volumn 87, Issue 12, 2009, Pages 1821-1829

  Heinze, Georg ^a   Oberbauer, Rainer ^a,b,c   Kainz, Alexander ^b   Mitterbauer, Christa ^a   Koppelstaetter, Christian ^d   Hörl, Walter H ^a   Mayer, Gert ^d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ELISABETHINEN HOSPITAL   (Austria)

^c Austrian Dialysis and Transplant Registry   (Austria)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Calcineurin inhibitors; Cyclosporine A; Donor age; Kidney transplantation; Outcome; Renal transplantation; Tacrolimus

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; EVEROLIMUS; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; AUSTRIA; CADAVER; CALCINEURIN; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; SURVIVAL RATE; SURVIVORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 67649619485     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181a66cfc     Document Type: Article

References (31)

1. USRDS Incidence and prevalence of ESRD. Annual Data Report. 2004; 58. Available at: www.usrds.org.
2. Stengel B, Billon S, Van Dijk PC, et al. Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. Nephrol Dial Transplant 2003; 18: 1824.
3. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725.
4. Mayer G, Persijn GG. Eurotransplant kidney allocation system (ETKAS): Rationale and implementation. Nephrol Dial Transplant 2006; 21: 2.
5. Ojo AO. Expanded criteria donors: Process and outcomes. Semin Dial 2005; 18: 463.
6. Schold JD, Srinivas TR, Howard RJ, et al. The association of candidate mortality rates with kidney transplant outcomes and center performance evaluations. Transplantation 2008; 85: 1.
7. Gjertson DW. Explainable variation in renal transplant outcomes: A comparison of standard and expanded criteria donors. Clin Transpl 2004: 303.
8. Morris PJ, Johnson RJ, Fuggle SV, et al. Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA). Lancet 1999; 354: 1147.
9. Oppenheimer F, Aljama P, Asensio Peinado C, et al. The impact of donor age on the results of renal transplantation. Nephrol Dial Transplant 2004; 19 (suppl 3): iii11.
10. Prommool S, Jhangri GS, Cockfield SM, et al. Time dependency of factors affecting renal allograft survival. J AmSoc Nephrol 2000; 11: 565.
11. Keith DS, Demattos A, Golconda M, et al. Effect of donor recipient age match on survival after first deceased donor renal transplantation.J Am Soc Nephrol 2004; 15: 1086.
12. Lucas BA, Vaughn WK, Spees EK, et al. Identification of donor factors predisposing to high discard rates of cadaver kidneys and increased graft loss within one year posttransplantation-SEOPF 1977-1982. South-Eastern Organ Procurement Foundation. Transplantation 1987; 43: 253.
13. Lee CM, Scandling JD, Shen GK, et al. The kidneys that nobody wanted: Support for the utilization of expanded criteria donors. Transplantation 1996; 62: 1832.
14. Cohen B, Smits JM, Haase B, et al. Expanding the donor pool to increase renal transplantation. Nephrol Dial Transplant 2005; 20: 34.
15. Frei U, Noeldeke J, Machold-Fabrizii V, et al. Prospective age matching in elderly kidney transplant recipients-a 5 year analysis of the Eurotransplant Senior Program. Am J Transplant 2008; 8: 50.
16. deFijter JW, Mallat MJK, Doxiadis IIN, et al. Increased immunogenicity and cause of graft loss of old donor kidneys. J Am Soc Nephrol 2001; 12: 1538.
17. Tang IY, Meier-Kriesche HU, Kaplan B. Immunosuppressive strategies to improve outcomes of kidney transplantation. Semin Nephrol 2007; 27: 377.
18. Ekberg H. Calcineurin inhibitor sparing in renal transplantation. Transplantation 2008; 86: 761.
19. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
20. Heinze G, Mitterbauer C, Regele H, et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 2006; 17: 889.
21. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457.
22. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc B 1972; 34: 187.
23. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994; 81: 515.
24. Heinzl H, Kaider A. Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions. Comput Methods Programs Biomed 1997; 54: 201.
25. Little RJA, Rubin DB. Statistical analysis with missing data [ed. 2]. New York, Wiley 2002.
26. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996; 17: 343.
27. Danovitch GM, Gill J, Bunnapradist S. Immunosuppression of the elderly kidney transplant recipient. Transplantation 2007; 84: 285.
28. Arbogast H, Hückelheim H, Schneeberger H, et al. A calcineurin inhibitor-free induction/maintenance strategy for immunosuppression in elderly recipients of renal allografts from elderly cadaver donors: Long term results from a prospective single centre trial. Clin Transplant 2005; 19: 309.
29. Legendre C, Brault Y, Morales JM, et al. Factors influencing glomerular filtration rate in renal transplantation after cyclosporine withdrawal using sirolimus based therapy: A multivariate analysis of results at five years. Clin Transplant 2007; 21: 330.
30. Grinyo JM, Gil-Vernet S, Cruzado JM, et al. Calcineurin inhibitor free immuno suppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: Results after 5 years. Transpl Int 2003; 16: 820.
31. Jennings P, Koppelstaetter C, Aydin S, et al. cyclosporine A induces senescence in renal tubular epithelial cells. Am J Physiol Renal Physiol 2007; 293: F831.